Abstract
Introduction: Diabetes mellitus is a prevalent global health concern associated with increased cardiovascular risk. Hypercoagulability is a prominent feature in diabetic patients, contributing to thrombotic complications. This study explores the coagulation profile in Type 2 diabetes mellitus (T2DM) patients, focusing on the correlation with glycated hemoglobin (HbA1c). Aim: The study aims to assess coagulation impairment in T2DM through routine prothrombin time (PT) and activated partial thromboplastin time (APTT) measurements, thereby preventing thromboembolic cardiovascular disease (CVD). It further examines the relationship between coagulation parameters, HbA1c, and diabetes duration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
